| CXSL2400072 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2024-01-31 | | Chengdu Rongsheng Pharmaceuticals Co Ltd | | | view |
| CXSL2300595 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2023-09-02 | | Hualan Biological Engineering Inc | | | view |
| CXSL1600041 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(7) | New Drug Application | 2016-07-11 | 四川远大蜀阳药业股份有限公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | Certificate Issued | 2016-12-08 | view |
| CXSL2300529 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.4) | New Drug Application | 2023-08-01 | | Guangdong Shuanglin Bio-Pharmacy Co Ltd | | | view |
| CXSS1900050 | 人凝血因子IX | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(7) | New Drug Application | 2019-12-26 | 四川远大蜀阳药业有限责任公司 | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | In Review | 2019-12-25 | view |
| CXSS1800007 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(7) | New Drug Application | 2018-04-16 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | Certificate Issued | 2020-07-16 | view |
| CXSL2500277 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(3.2) | New Drug Application | 2025-04-08 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2300115 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2023-06-14 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2100054 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2021-02-05 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | In Review | 2022-01-25 | view |
| CYSB2500044 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-02-19 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CXSL1600003 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(7) | New Drug Application | 2016-02-16 | 山东泰邦生物制品有限公司 | Shandong Taibang Biological Products Co Ltd | Certificate Issued | 2016-09-04 | view |
| CYSB2400105 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2024-05-08 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2400043 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products(原7) | Supplementary Application | 2024-02-20 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CYSB2500113 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2025-05-20 | | Sichuan Yuanda Shuyang Pharmaceutical Co Ltd | | | view |
| CYSB2300147 | 人凝血因子Ⅸ | Human Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2023-07-28 | | Shandong Taibang Biological Products Co Ltd | | | view |
| CXSL2300260 | 注射用培重组人凝血因子IX-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2023-04-14 | | Zhengzhou Shengsi Biotechnology Co Ltd | | | view |
| CXSL2300259 | 注射用培重组人凝血因子IX-Fc融合蛋白 | | Lyophilized | Biological Products(1) | New Drug Application | 2023-04-14 | | Zhengzhou Shengsi Biotechnology Co Ltd | | | view |
| JYSB1600079 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2016-05-10 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | Certificate Issued | 2018-07-17 | view |
| JYSB2101101 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2021-08-10 | | Pfizer Europe Ma Eeig;Wyeth Farma SA | | | view |
| JYSB1300162 | 注射用重组人凝血因子IX | Recombinant Coagulation Factor Ⅸ | Lyophilized | Biological Products | Supplementary Application | 2013-07-23 | | Wyeth Farma SA;Wyeth Pharmaceuticals Inc | In Review | 2013-07-19 | view |
